Haley Hedlin, Ph.D.
Senior Biostatistician
Associate Director, Clinical Trials Program
Dr. Hedlin joined the QSU in 2013 after completing a postdoctoral position with the Five Colleges Consortium. She received her PhD in Biostatistics from Johns Hopkins in 2011. In her position, she collaborates closely with clinical researchers to design and implement studies and apply statistical methods. In her work, she has contributed to medicine and public health research on women's health, cardiovascular and pulmonary diseases, and data safety monitoring.
Methodology Area of Interest: data safety monitoring; longitudinal, and clustered data; data visualization
Selected Publications:
Bunning B, Hedlin H, Purington N, et al. The COVID-19 Outpatient Pragmatic Platform Study (COPPS): Study design of a multi-center pragmatic platform trial. Contemp Clin Trials. 2021;108:106509. doi:10.1016/j.cct.2021.106509
Hedlin H, Garcia A, Weng Y, et al. Clinical trials in a COVID-19 pandemic: Shared infrastructure for continuous learning in a rapidly changing landscape. Clin Trials. 2021;18(3):324-334. doi:10.1177/1740774520988298
Rosas LG, Vasquez JJ, Hedlin HK, et al. Comparing enhanced versus standard Diabetes Prevention Program among indigenous adults in an urban setting: a randomized controlled trial. BMC Public Health. 2020;20(1):139. Published 2020 Jan 30. doi:10.1186/s12889-020-8250-7
Lough ME, Shradar E, Hsieh C, Hedlin H. Contamination in Adult Midstream Clean-Catch Urine Cultures in the Emergency Department: A Randomized Controlled Trial. J Emerg Nurs. 2019;45(5):488-501. doi:10.1016/j.jen.2019.06.001
Turakhia MP, Desai M, Hedlin H, et al. Rationale and design of a large-scale, app-based study to identify cardiac arrhythmias using a smartwatch: The Apple Heart Study. American heart journal, 2019;207:66-75.
Perez MV, Mahaffey KW, Hedlin H, et al. Large-Scale Assessment of a Smartwatch to Identify Atrial Fibrillation. N Engl J Med. 2019;381(20):1909-1917. doi:10.1056/NEJMoa1901183
Zamanian RT, Hedlin H, Greuenwald P, et al. Features and Outcomes of Methamphetamine-associated Pulmonary Arterial Hypertension. Am J Respir Crit Care Med. 2018;197(6):788-800. doi:10.1164/rccm.201705-0943OC